Pathological diagnosis of malignant pleural mesothelioma

Françoise Galateau-Salle (Caen, France)

Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases

Number: 3

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Françoise Galateau-Salle (Caen, France). Pathological diagnosis of malignant pleural mesothelioma. ERS Online Course 2020: Calendar sheets in malignant pleural diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Diagnosis of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Diagnosis and staging of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014
Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016
Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012
Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006
Thoracoscopy and malignant pleural mesothelioma Source: ERS Course 2015 Year: 2015
Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006
Non-malignant pleural disease from asbestos and malignant pleural mesothelioma Source: Eur Respir Monogr 2020; 89: 141-149 Year: 2020
Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 74s Year: 2005
Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma? Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Management of malignant pleural mesothelioma in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017
Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Management of malignant pleural effusions Source: Guideline 2001 Year: 2001